ES483500A1 - Glaucine lactate salts - Google Patents

Glaucine lactate salts

Info

Publication number
ES483500A1
ES483500A1 ES483500A ES483500A ES483500A1 ES 483500 A1 ES483500 A1 ES 483500A1 ES 483500 A ES483500 A ES 483500A ES 483500 A ES483500 A ES 483500A ES 483500 A1 ES483500 A1 ES 483500A1
Authority
ES
Spain
Prior art keywords
lactate salts
glaucine
glaucine lactate
salts
antitussive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES483500A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dow Chemical Co
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of ES483500A1 publication Critical patent/ES483500A1/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04Ortho- or peri-condensed ring systems
    • C07D221/18Ring systems of four or more rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Lactate salts of l-glaucine and d,l- glaucine having antitussive and analgesic properties, which additionally have good stability and palatability.
ES483500A 1978-08-21 1979-08-20 Glaucine lactate salts Expired ES483500A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US93522078A 1978-08-21 1978-08-21

Publications (1)

Publication Number Publication Date
ES483500A1 true ES483500A1 (en) 1980-04-16

Family

ID=25466733

Family Applications (1)

Application Number Title Priority Date Filing Date
ES483500A Expired ES483500A1 (en) 1978-08-21 1979-08-20 Glaucine lactate salts

Country Status (22)

Country Link
JP (1) JPS5540672A (en)
AT (1) AT372374B (en)
AU (1) AU529554B2 (en)
BE (1) BE878355A (en)
CA (1) CA1109473A (en)
CH (1) CH641164A5 (en)
DE (1) DE2932833A1 (en)
DK (1) DK347279A (en)
ES (1) ES483500A1 (en)
FI (1) FI68812C (en)
FR (1) FR2434152A1 (en)
GB (1) GB2028323B (en)
GR (1) GR69851B (en)
IE (1) IE49057B1 (en)
IL (1) IL57934A (en)
IT (1) IT1123511B (en)
NL (1) NL7906216A (en)
NO (1) NO150001C (en)
NZ (1) NZ191171A (en)
PT (1) PT70097A (en)
SE (1) SE7906940L (en)
ZA (1) ZA794134B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2130531A1 (en) * 2008-06-04 2009-12-09 Rolf Kullgren AB Vaginal suppository comprising lactic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2717001C2 (en) * 1977-04-18 1984-06-20 Karl O. Helm Ag, 2000 Hamburg Medicines with an antithrombotic effect
DE2717062C2 (en) * 1977-04-18 1982-11-25 Karl O. Helm Ag, 2000 Hamburg Medicines with an antitussive effect

Also Published As

Publication number Publication date
AU529554B2 (en) 1983-06-09
GR69851B (en) 1982-07-19
FI68812C (en) 1985-11-11
FI792357A7 (en) 1980-02-22
CA1109473A (en) 1981-09-22
JPS5540672A (en) 1980-03-22
IL57934A (en) 1983-12-30
ZA794134B (en) 1980-08-27
NO150001C (en) 1984-08-01
AU4935879A (en) 1981-02-26
NL7906216A (en) 1980-02-25
NO150001B (en) 1984-04-24
IE791597L (en) 1980-02-21
ATA558479A (en) 1983-02-15
NZ191171A (en) 1984-05-31
SE7906940L (en) 1980-02-22
PT70097A (en) 1979-09-01
IT1123511B (en) 1986-04-30
GB2028323B (en) 1982-12-15
FI68812B (en) 1985-07-31
IL57934A0 (en) 1979-11-30
AT372374B (en) 1983-09-26
DK347279A (en) 1980-02-22
NO792704L (en) 1980-02-22
CH641164A5 (en) 1984-02-15
FR2434152A1 (en) 1980-03-21
IE49057B1 (en) 1985-07-24
IT7924782A0 (en) 1979-07-31
GB2028323A (en) 1980-03-05
DE2932833A1 (en) 1980-03-06
FR2434152B1 (en) 1982-11-19
BE878355A (en) 1980-02-21

Similar Documents

Publication Publication Date Title
AU559218B2 (en) Improved analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
SE8503762L (en) ANALGETIC AND ANTI-INFLAMMATORY COMPOSITIONS CONTAINING XANTINES AND PROCEDURE FOR USING THESE
ES2061432T3 (en) NEW ACRYLIC ACID AMIDES.
EP0013983A3 (en) Antineoplastics on the basis of little or non-irritating diterpenalcohols,and derivatives thereof, and their preparation
ES2140565T3 (en) NEW DERIVATIVES OF PIRAZINE-CARBOXAMIDE, ITS PREPARATION AND ITS USE IN MEDICINES.
GR850309B (en)
IT7926901A0 (en) IMPROVEMENTS OF PROCEDURES AND EQUIPMENT FOR THE DISINTEGRATION OF CELLULOSIC MATERIALS.
EP0152425A4 (en) Stable dispersions of organic polymers in polyepoxides.
BG47648A3 (en) Method for preparing of triazolyl quanolinic compounds
FI852973A7 (en) 3-Carbonyl-1-aminoalkyl-1H-indoles useful as analgesic agents and their preparation.
ES483500A1 (en) Glaucine lactate salts
EG17890A (en) Improved antiinflammatory compositions and methods
ES2044100T3 (en) CERTAIN COMBINATIONS OF "PAF" ANTAGONISTS AND ANTIHISTAMINICS AND METHODS.
ES483499A1 (en) Glaucine phosphate salts
GB2014141A (en) 8???-ethyl- and 8???-methyl-4,5??? epoxymorphinan-6-one compounds
DE2962236D1 (en) Non-ionic compounds based on modified natural resins, their manufacture and their use as surface-active agents
ES8302680A1 (en) "A PROCEDURE FOR SYNTHESIZING 3 (4-PHENYL-1-PIPERACINIO-1-IL) -1,2-PROPANDIOL 3 (TEOFILIN-7-IL) -1-PROPANSULFONATE"
ES8608887A1 (en) Mixture, manufacturing process and application as a drug.
KE3478A (en) N-substituted-6-oxamorphinans
ES456281A1 (en) 2,5-Dimethyl-benzo(b) thiene (3,2-f) morphan and precursor thereof
SU640003A1 (en) Butt joint
ES8800666A1 (en) 1,4-Dihydropyridine derivatives, process for their preparation and their use in medicaments.
ES385521A1 (en) Azamorphinan compounds
IL79352A (en) Quinoline-8-carboxylic acid azolides,their manufacture and their use as herbicides
ES448550A1 (en) 6-Aminomethylated 3-oxygenated cholest-5-enes